JP2020527051A - 家禽における壊疽性腸炎に対するワクチン - Google Patents

家禽における壊疽性腸炎に対するワクチン Download PDF

Info

Publication number
JP2020527051A
JP2020527051A JP2020517243A JP2020517243A JP2020527051A JP 2020527051 A JP2020527051 A JP 2020527051A JP 2020517243 A JP2020517243 A JP 2020517243A JP 2020517243 A JP2020517243 A JP 2020517243A JP 2020527051 A JP2020527051 A JP 2020527051A
Authority
JP
Japan
Prior art keywords
polypeptide
seq
poultry
immunogenic
pili
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020517243A
Other languages
English (en)
Japanese (ja)
Inventor
ゴン，ジェンホワ
レップ，ディオン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture and Agri-Food Canada
Original Assignee
Agriculture and Agri-Food Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agriculture and Agri-Food Canada filed Critical Agriculture and Agri-Food Canada
Publication of JP2020527051A publication Critical patent/JP2020527051A/ja
Priority to JP2023020473A priority Critical patent/JP2023090702A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2020517243A 2017-05-31 2018-05-31 家禽における壊疽性腸炎に対するワクチン Pending JP2020527051A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023020473A JP2023090702A (ja) 2017-05-31 2023-02-14 家禽における壊疽性腸炎に対するワクチン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762513001P 2017-05-31 2017-05-31
US62/513,001 2017-05-31
PCT/CA2018/050643 WO2018218360A1 (en) 2017-05-31 2018-05-31 Vaccine against necrotic enteritis in poultry

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023020473A Division JP2023090702A (ja) 2017-05-31 2023-02-14 家禽における壊疽性腸炎に対するワクチン

Publications (1)

Publication Number Publication Date
JP2020527051A true JP2020527051A (ja) 2020-09-03

Family

ID=64454163

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020517243A Pending JP2020527051A (ja) 2017-05-31 2018-05-31 家禽における壊疽性腸炎に対するワクチン
JP2023020473A Pending JP2023090702A (ja) 2017-05-31 2023-02-14 家禽における壊疽性腸炎に対するワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023020473A Pending JP2023090702A (ja) 2017-05-31 2023-02-14 家禽における壊疽性腸炎に対するワクチン

Country Status (8)

Country Link
US (2) US11318194B2 (https=)
EP (1) EP3630800A4 (https=)
JP (2) JP2020527051A (https=)
CN (1) CN110691787A (https=)
BR (1) BR112019025019A2 (https=)
CA (1) CA3064461A1 (https=)
MX (1) MX2019014450A (https=)
WO (1) WO2018218360A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234130A (zh) * 2021-05-24 2021-08-10 安徽医科大学第四附属医院 一种卡氏肺孢子菌重组蛋白及其制备方法与应用
WO2025199604A1 (en) * 2024-03-27 2025-10-02 Université de Montréal Recombinant vaccine proteins for the prevention of avian necrotic enteritis

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080102079A1 (en) * 2006-10-27 2008-05-01 Dow Agrosciences Llc Poultry Vaccine, for Necrotic Enteritis, Comprising a Mutated Clostridium Perfringens Alpha Toxin Antigen, and Methods of Producing the Vaccine
JP2008536936A (ja) * 2005-04-18 2008-09-11 シェーリング−プラウ・リミテッド ウェルシュ菌αトキソイドワクチン
JP2009538116A (ja) * 2006-02-17 2009-11-05 ノバルティス アーゲー 細菌抗原の精製
JP2010510197A (ja) * 2006-11-20 2010-04-02 インターベツト・インターナシヨナル・ベー・ベー ワクチンの製造のためのクロストリジウム・パーフリンジェンスｃ型細菌の使用
JP2010529838A (ja) * 2007-06-08 2010-09-02 オーストラリアン ポールトリー シーアールシー ピーティーワイ リミテッド クロストリジウム毒素ｎｅｔｂ
US20100255022A1 (en) * 2007-06-22 2010-10-07 University Of Guelph Vaccine against clostridium perfringens
US20110097360A1 (en) * 2007-05-25 2011-04-28 Claudio Donati Streptococcus pneumoniae pilus antigens
JP2017505807A (ja) * 2014-02-17 2017-02-23 インターベット インターナショナル ベー． フェー． 液体安定である家禽ウイルスワクチン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958962A3 (en) * 1997-06-12 2013-05-01 Novartis International Pharmaceutical Ltd. Artificial antibody polypeptides
AU6094000A (en) * 1999-07-13 2001-01-30 Med Immune, Inc. Donor strand complemented pilin and adhesin broad-based vaccines
WO2011113801A1 (en) * 2010-03-16 2011-09-22 Universiteit Gent Use of clostridium perfringens strain 23 to protect against necrotic enteritis
FR3065623B1 (fr) * 2017-04-28 2021-07-09 Roquette Freres Albumines de pois ameliorees, procede d'obtention et leurs applications
MX2021000184A (es) * 2018-07-05 2021-05-12 Novobind Livestock Therapeutics Inc Anticuerpos contra agentes patogenos en aves de corral y sus aplicaciones.

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008536936A (ja) * 2005-04-18 2008-09-11 シェーリング−プラウ・リミテッド ウェルシュ菌αトキソイドワクチン
JP2009538116A (ja) * 2006-02-17 2009-11-05 ノバルティス アーゲー 細菌抗原の精製
US20080102079A1 (en) * 2006-10-27 2008-05-01 Dow Agrosciences Llc Poultry Vaccine, for Necrotic Enteritis, Comprising a Mutated Clostridium Perfringens Alpha Toxin Antigen, and Methods of Producing the Vaccine
JP2010510197A (ja) * 2006-11-20 2010-04-02 インターベツト・インターナシヨナル・ベー・ベー ワクチンの製造のためのクロストリジウム・パーフリンジェンスｃ型細菌の使用
US20110097360A1 (en) * 2007-05-25 2011-04-28 Claudio Donati Streptococcus pneumoniae pilus antigens
JP2010529838A (ja) * 2007-06-08 2010-09-02 オーストラリアン ポールトリー シーアールシー ピーティーワイ リミテッド クロストリジウム毒素ｎｅｔｂ
US20100255022A1 (en) * 2007-06-22 2010-10-07 University Of Guelph Vaccine against clostridium perfringens
JP2017505807A (ja) * 2014-02-17 2017-02-23 インターベット インターナショナル ベー． フェー． 液体安定である家禽ウイルスワクチン

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [ONLINE], ACCESSION NO.ALJ54440 <URL: HTTPS://WWW.NCBI.NLM.NIH.GOV/PROTEIN/ALJ54440, JPN6022011988, ISSN: 0005028957 *
DATABASE GENBANK [ONLINE], ACCESSION NO.AQW25808 <URL: HTTPS://WWW.NCBI.NLM.NIH.GOV/PROTEIN/AQW25808, JPN6022011987, ISSN: 0005028958 *
DATABASE GENBANK [ONLINE], ACCESSION NO.AQW25810 <URL: HTTPS://WWW.NCBI.NLM.NIH.GOV/PROTEIN/AQW25810, JPN6022011985, ISSN: 0005028959 *

Also Published As

Publication number Publication date
JP2023090702A (ja) 2023-06-29
RU2019137515A3 (https=) 2021-12-03
EP3630800A1 (en) 2020-04-08
CA3064461A1 (en) 2018-12-06
US11318194B2 (en) 2022-05-03
BR112019025019A2 (pt) 2020-06-30
US20200093913A1 (en) 2020-03-26
MX2019014450A (es) 2020-02-10
EP3630800A4 (en) 2021-03-24
CN110691787A (zh) 2020-01-14
WO2018218360A1 (en) 2018-12-06
US20220226455A1 (en) 2022-07-21
RU2019137515A (ru) 2021-06-30

Similar Documents

Publication Publication Date Title
EA001789B1 (ru) Выделенные, по существу очищенные, поверхностные антигены белковой природы neisseria meningitidis и neisseria gonorrhoeae, их фрагменты и последовательности днк
JP6434017B2 (ja) マイコプラズマ属菌種の感染を予防する組成物
JP2023090702A (ja) 家禽における壊疽性腸炎に対するワクチン
Lepp et al. Immunization with subunits of a novel pilus produced by virulent Clostridium perfringens strains confers partial protection against necrotic enteritis in chickens
CN1323162C (zh) 副结核分枝杆菌感染的诊断和疫苗
JP4160640B2 (ja) クラミジア・ニューモニエ由来の表面露出タンパク質
JP4368944B2 (ja) 防御用ヘリコバクター抗原
JP4081140B2 (ja) 非耐熱性エンテロトキシンとコレラトキシンｂサブユニットの雑種分子
McNeilly et al. IgA and IgG antibody responses following systemic immunization of cattle with native H7 flagellin differ in epitope recognition and capacity to neutralise TLR5 signalling
CA2825282A1 (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
Singh et al. Molecular heterogeneity of plpE gene in Indian isolates of Pasteurella multocida and expression of recombinant PlpE in vaccine strain of P. multocida serotype B: 2
US20080279893A1 (en) Lawsonia intracellularis immunological proteins
EP1694697B1 (en) Surface-located campylobacter jejuni polypeptides
CA2516661C (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
CN117510626A (zh) 产气荚膜梭菌蛋白ArcB、rpsB、TmpC多克隆抗体的制备和应用
RU2788096C2 (ru) Вакцина против некротического энтерита у домашней птицы
WO2007081938A2 (en) Mannheimia haemolytica chimeric outer membrane protein plpe and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
HK40019772A (en) Vaccine against necrotic enteritis in poultry
JP4500615B2 (ja) エリシペロトリックス属のその他の菌種である血清型１８由来の豚丹毒菌感染防御活性を有する新規ポリペプチドとその遺伝子および製法
CN111150839A (zh) 一种用于免疫接种的组合物及其制备方法
US20250152689A1 (en) Vaccine against leptospirosis
WO2000044905A1 (fr) Polypeptide de bacterie acidoresistante a croissance faible
WO2024086846A1 (en) Methods and compositions for immunizing against campylobactor hepaticus
PL201982B1 (pl) Przeciwciała poliklonalne przeciwko białkom Helicobacter pylori oraz sposób ich wytwarzania
HK1097854B (en) Surface-located campylobacter jejuni polypeptides

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210528

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220628

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221014

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230214

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230214

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20230222

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230314

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20230315

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230407

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20230411